Venlafaxine Hydrochloride
Product Images NDC 50090-6215

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Image 1)

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement with a methoxy group, dimethylamino group, cyclohexanol ring, and hydrochloride attachment.*

FDA Label Image

1 (Image 2)

A dot plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its ODV metabolite across special populations. The chart compares hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism (poor/extensive metabolizer), age (>60 years), and gender (females/males), relative to a reference value.*

FDA Label Image

2 (Image 3)

A scatter plot depicting the fold change and 90% confidence intervals for various pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine when co-administered with different interacting drugs, including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents the change relative to the reference value, ranging from 0 to 3.*

FDA Label Image

3 (Image 4)

A scatter plot chart titled "Fold Change and 90% CI" presenting the fold change relative to a reference value for various analytes of interacting drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. Points correspond to Cmax and AUC pharmacokinetic parameters with error bars illustrating 90% confidence intervals.*

FDA Label Image

Label Image (Lbl500906215)

Venlafaxine Hydrochloride Extended-Release 75 mg capsules label by A-S Medication Solutions, Libertyville, IL. The label instructs storage at 60 to 77 degrees Fahrenheit protected from light, and indicates a package of 29 unit-dose capsules. Includes dosage instructions and NDC 50090-6215.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.